Longitudinal study of humoral and cellular responses to COVID-19 mRNA vaccines with and without 3rd ("booster") dose in MS patients on ocrelizumab: 24-week results from VIOLA (NCT04843774)

I. Kister, A. Piquet, R. Curtin, A. Yu, I. Voloshyna,V. Yogambigai,S. Nyovanie,A. Lopez, F. Dibba,J. Kim, I. Stanzin, K. Perdomo, T. Borko, S. Selva, J. Parra Gonzales, T. Bacon, M. Samanovic-Golden, P. Raut, C. Raposo, J. Priest, R. Winger, J. Pei,M. Mulligan,Y. Patskovsky,G. Silverman,M. Krogsgaard

MULTIPLE SCLEROSIS JOURNAL(2022)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要